Answers are grounded in this paper and cite their sources.
Post-marketing surveillance is essential to detect, assess and prevent adverse reactions of chemically synthesized small molecule drugs as well as biologicals, as the full safety profi le can only be known after they have been placed on the market.Biologicals have specifi c characteristics, which pose additional challenges in pharmacovigilance.
No takes yet. Share an insight, caveat, or question.
Thijs J. Giezen (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: